Dermata Therapeutics, Inc. (DRMA) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Dermata Therapeutics, Inc. (DRMA) closed at USD 0.66 on 2026-10-14, a change of -82.4 % over the past year, with a market capitalization of USD 4.51M.

Dermata Therapeutics, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Dermata Therapeutics, Inc. key figures

Previous close

USD 0.66 (2026-10-14)

1-year change

-82.4 %

Market cap

USD 4.51M

Enterprise value

USD -752,613

P/E ratio (trailing)

-0.19

P/E ratio (forward)

-0.24

EPS (trailing)

-4.69

EPS (forward)

-3.87

PEG ratio

n/a

Price to book

1.05

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

2.61

Employees

9

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Dermata Therapeutics, Inc.

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Dermata Therapeutics, Inc. and compare it with other stocks.